Zetia new york times

14 Jan 2008 A clinical trial of Zetia, a cholesterol-lowering drug prescribed to about 1 million people a week, failed to show that the drug has any medical Trade names, Zetia It may be used alone (marketed as Zetia or Ezetrol), when other cholesterol-lowering . Jump up Gina Kolata for the New York Times

6 May 2013 This is extremely surprising and disturbing, the Cleveland Clinic39s Dr. Steven E. Nissen told The New York Times. In Forbes, Nissen expanded

In December 2007 the New York Times reported that Merck and Schering-Plough had conducted a number of Zetia studies that indicated the possibility of Zetia There has been a lot of controversy and news on zetia and vytorin recently. LifeWire, a part of The New York Times Company, provides original and 15 Nov 2009 A study shows the heavily marketed Zetia was inferior to an old standby drug, niacin, in reducing buildup in the carotid artery. New York Times Zetia, a newer drug that reduces bad cholesterol, according to a new study

Drug Has No Benefit in Trial, Makers Say - New York Times

18 Nov 2014 NEW YORK For the first time since statins have been regularly used, a large study has found that another type of cholesterol-lowering drug 12 Dec 2007 A Congressional committee is investigating Merck and Schering-Plough for their handling of a critical clinical trial of Zetia, their blockbuster

23 Mar 2008 14 (HealthDay News)-- The long-awaited results of a trial of Zetia, According to The New York Times, the companies had initially planned to 16 Aug 2013 In 2007, The New York Times reported that the makers of Zetia, Plough- Schering and Merck, studied the drug for its ability to cause liver